Eargo | Jotup

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EAR, PEAK

Retrieved on:

Mardi, octobre 31, 2023

Healthpeak Properties, Sale, Fraud, Advertising, NYSE, Eargo, Security (finance)

If you are an Eargo shareholder, click here to learn more about your rights and options .

Key Points:

If you are an Eargo shareholder, click here to learn more about your rights and options .
If you are a Healthpeak shareholder, click here to learn more about your rights and options .
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)

Retrieved on:

Lundi, octobre 30, 2023

United Therapeutics, NYSE, Eargo, Brodsky, Tripura Merger Agreement, Realty Income, Healthpeak Properties, UTHR, Spirit, Therapy, Security (finance)

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points:

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Under the terms of the agreement, Spirit Realty will be acquired by Realty Income Corporation (“Realty Income”) (NYSE – O).
Spirit Realty shareholders will receive 0.762 newly-issued Realty Income common shares for each Spirit common share they own.
At closing, this will result in Realty Income and Spirit Realty shareholders owning approximately 87% and 13%, respectively, of the combined company.

EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR

Retrieved on:

Mercredi, novembre 1, 2023

Class Action Lawsuit, Professional Services, Legal, Sale, EAR, KSF, Eargo

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eargo, Inc. (NasdaqGS: EAR) to an affiliate of Patient Square Capital.

Key Points:

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eargo, Inc. (NasdaqGS: EAR) to an affiliate of Patient Square Capital.
Under the terms of the proposed transaction, shareholders of Eargo will receive $2.55 in cash for each share of Eargo that they own.
KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

EAR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Eargo, Inc. Is Fair to Shareholders

Retrieved on:

Lundi, octobre 30, 2023

Class Action Lawsuit, Professional Services, Legal, Sale, EAR, Fraud, Advertising, Security (finance), Eargo

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Eargo, Inc. (NASDAQ: EAR) to an affiliate of Patient Square Capital for $2.55 per share in cash is fair to Eargo shareholders.

Key Points:

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Eargo, Inc. (NASDAQ: EAR) to an affiliate of Patient Square Capital for $2.55 per share in cash is fair to Eargo shareholders.
On behalf of Eargo shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 Locations

Retrieved on:

Jeudi, octobre 26, 2023

Quality of life, Hearing loss, FDA, EAR, Best Buy, Kool-Aid, Interim, SAN, Music, Management, Eargo

Eargo devices are now on display in more than 500 Best Buy stores, marking another step in Eargo’s retail journey.

Key Points:

Eargo devices are now on display in more than 500 Best Buy stores, marking another step in Eargo’s retail journey.
Approximately 250 of these Best Buy locations will carry Eargo 5–an over-the-counter, FDA-cleared and self-fitting hearing aid–allowing customers to see Eargo’s virtually invisible design and purchase in store.
Through this expansion, Eargo continues its mission to make hearing wellness more accessible, reaching more people where they are across the country.
Eargo is proud to continue our commitment to improving lives through better hearing.”

Eargo Reports Second Quarter 2023 Financial Results

Retrieved on:

Jeudi, août 10, 2023

Workforce, Insurance, Interim, Partnership, Marketing, Research, Burn, EAR, Acquisition, SAN, OTC, Kool-Aid, Software, Video game, Mobile phone, Pharmaceutical industry, Bank, Eargo, GAAP

SAN JOSE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the second quarter ended June 30, 2023.

Key Points:

Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-year
Gross systems shipped of 5,098, up 14% year-over-year
GAAP total operating loss $25.8 million in the second quarter of 2023, compared to $31.4 million in the second quarter of 2022
In connection with the implementation of the announced cost reduction plan, the Company expects to extend net operating cash runway into the second half of 2024
SAN JOSE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the second quarter ended June 30, 2023.
Gross systems shipped for the second quarter of 2023 were 5,098, compared to 4,455 during the second quarter of 2022.
The sales returns rate for the second quarter of 2023 was 34.2%, compared to 33.3% in the second quarter of 2022.
Net revenue was $8.1 million for the second quarter of 2023, compared to $7.2 million for the second quarter of 2022.

Eargo Reports First Quarter 2023 Financial Results

Retrieved on:

Jeudi, mai 11, 2023

Insurance, Justice minister, Justice, Marketing, Research, EAR, Retirement Insurance Benefits, Investment, SAN, Video game, Mobile phone, Bank, Cryptocurrency, Eargo, GAAP

SAN JOSE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the first quarter ended March 31, 2023.

Key Points:

Net revenues of $11.8 million in the first quarter of 2023, up 29% year-over-year
Gross systems shipped of 8,705, up 51% year-over-year
GAAP total operating loss $22.8 million in the first quarter of 2023, compared to $30.4 million in the first quarter of 2022
Commercially launched Eargo 7, a self-fitting hearing aid with the use of Sound Match via our mobile app, in February 2023
SAN JOSE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the first quarter ended March 31, 2023.
The sales returns rate for the first quarter of 2023 was 37.4%, compared to 33.9% in the first quarter of 2022.
Net revenue was $11.8 million for the first quarter of 2023, compared to $9.2 million for the first quarter of 2022.
Eargo will host a conference call to discuss the first quarter financial results after market close on May 11, 2023, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Eargo to Report First Quarter 2023 Financial Results on May 11, 2023

Retrieved on:

Jeudi, mai 4, 2023

Telephone, Eargo, Interest, Webcast, SAN, EAR, Mobile phone, Online shopping

SAN JOSE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023.

Key Points:

SAN JOSE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023.
On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.
Interested parties may access the live call via telephone by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using conference ID: 2789592.
The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com.

Patient Square Capital Promotes Justin Sabet-Peyman to Partner

Retrieved on:

Vendredi, avril 14, 2023

Partnership, Stanford University, McKinsey & Company, Eargo, KKR, Investment, Access, Justin, Growth, Telecare, Nursing

MENLO PARK, Calif., April 14, 2023 /PRNewswire/ -- Patient Square Capital ("Patient Square"), a leading health care investment firm, announced today that Justin Sabet-Peyman has been promoted to Partner, a reflection of the firm's growing leadership team.

Key Points:

MENLO PARK, Calif., April 14, 2023 /PRNewswire/ -- Patient Square Capital ("Patient Square"), a leading health care investment firm, announced today that Justin Sabet-Peyman has been promoted to Partner, a reflection of the firm's growing leadership team.
Mr. Sabet-Peyman has led investments in companies across several health care subsectors and currently serves on the Boards of Directors of Patient Square portfolio companies including Access TeleCare and Eargo.
"Justin and I have worked together for over a dozen years, and I have seen firsthand his growth as an investor, board member and leader," said Jim Momtazee, Managing Partner of Patient Square.
Mr. Sabet-Peyman joined Patient Square Capital in 2021 and previously worked on KKR's Americas Health Care Team for over ten years where he focused on private equity and growth equity investing.

Eargo Reports Fourth Quarter 2022 Financial Results

Retrieved on:

Jeudi, mars 23, 2023

Insurance, Learning, Partnership, Marketing, DOJ, GAAP, Research, EAR, ESPP, Retirement Insurance Benefits, SAN, Security (finance), Video game, Cryptocurrency, Pharmaceutical industry, Eargo

SAN JOSE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the fourth quarter ended December 31, 2022.

Key Points:

Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022
Gross systems shipped of 8,863, compared to 7,767 in the fourth quarter of 2021
GAAP operating loss $23.9 million in the fourth quarter of 2022, compared to $45.2 million in the fourth quarter of 2021 and $26.0 million in the third quarter of 2022
Cash and cash equivalents of $101.2 million as of December 31, 2022
SAN JOSE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the fourth quarter ended December 31, 2022.
Gross systems shipped for the fourth quarter of 2022 were 8,863, compared to 7,767 during the fourth quarter of 2021.
Net revenue was $12.9 million for the fourth quarter of 2022, compared to $10.1 million for the fourth quarter of 2021.
Gross margin was 47.7% for the fourth quarter of 2022, compared with 24.0% for the fourth quarter of 2021.